Trial Profile
Placebo-controlled trial of Cipralex [escitalopram] in the treatment of negative symptoms in schizophrenia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 01 Aug 2010 Results have been published in Psychiatry Research.
- 10 Dec 2005 New trial record.